The Impact Of CD56neg NK Cells in the Pathogenesis of Endemic Burkitt Lymphoma |
University of Massachusetts Medical School / Catherine Forconi, PhD |
Young Investigator Grants |
2019 |
Massachusetts |
Characterization of Chromatin Landscapes to Identify Therapeutic Vulnerabilities in Diffuse Midline Gliomas. |
Fred Hutchinson Cancer Research Center / Jay Sarthy, MD/PhD |
Young Investigator Grants |
2019 |
Washington |
Dissecting Microenvironmental Interactions in Pediatric High-Grade Gliomas that Promote Tumor Growth |
Dana-Farber Cancer Institute / Mariella G. Filbin, MD/PhD |
Crazy 8 Pilots |
2019 |
Massachusetts |
Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma |
The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD |
'A' Award Grants |
2019 |
California |
Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow |
University of Colorado Denver / Siddhartha S. Mitra, PhD |
Crazy 8 Pilots |
2019 |
Colorado |
The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade |
University of Florida / Catherine Flores, PhD |
Innovation Grants |
2019 |
Florida |
Overcoming Obstacles to Drug Development in Pediatric Cancer |
Stanford University School of Medicine / Crystal L. Mackall, MD |
Crazy 8 Pilots |
2019 |
California |
Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies |
Emory University / Christopher Porter, MD |
Innovation Grants |
2019 |
Georgia |
Platform development for target identification in high risk pediatric leukemias |
St. Jude Children’s Research Hospital / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD |
Crazy 8 Pilots |
2019 |
Tennessee |
Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma |
Children’s Hospital of Philadelphia / Michael Chorny, PhD |
Innovation Grants |
2019 |
Pennsylvania |